Oversee site monitoring and protocol compliance for Phase II and Phase III oncology clinical trials. Responsibilities include conducting pre-study site evaluations, routine monitoring visits, and closeout procedures across assigned hospital sites. Verifies informed consent forms, audits electronic case report forms (eCRF) against source document evidence, tracks investigational product accountability, and ensures strict adherence to GCP and CDSCO guidelines
